Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(2.08) per share. This is a 48 percent increase over losses of $(4.00) per share from the same period last year.
Deutsche Bank Maintains Buy on Bill.com Holdings, Lowers Price Target to $150
Deutsche Bank analyst Bryan Keane maintains Bill.com Holdings (NYSE:BILL) with a Buy and lowers the price target from $200 to $150.